US EditionNeurocrine Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
Neurocrine CEO Kyle Gano will provide company updates and showcase its diverse portfolio and pipeline during a live webcast at the 44th Annual J.P. Morgan Healthcare Conference.
- On Monday, January 12, 2026, Neurocrine Biosciences, Inc. will present at the 44th Annual J.P. Morgan Healthcare Conference at 9:45 a.m. Pacific Time, with Kyle Gano, Chief Executive Officer, delivering the presentation webcast live on Neurocrine Biosciences' Investors webpage.
- The Jan. 5, 2026 press release noted Neurocrine Biosciences, Inc. included forward-looking statements and cautioned readers and investors under Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.
- Neurocrine Biosciences, a neuroscience-focused company, says it relentlessly pursues medicines to ease burdens for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders.
- The conference provides a platform to engage investors, allowing company management teams to highlight strategy and progress to the global investment and healthcare community.
- Noting uncertainty, Neurocrine stressed the non-guaranteed nature of future statements, warning forward-looking statements involve risks and uncertainties that may cause actual results to differ, the release stated.
55 Articles
55 Articles
Pacira BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conferences
BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will present at the 44th…
Amphastar Pharmaceuticals to Present at the J.P. Morgan 2026 Healthcare Conference
RANCHO CUCAMONGA, CA / ACCESS Newswire / January 7, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Jack Zhang, CEO and President, and Bill Peters, CFO will be presenting at the J.P. Morgan 2026 Healthcare Conference on Wednesday, January…
Celltrion to present at the 44th Annual J.P. Morgan Healthcare Conference
INCHEON, South Korea, Jan. 6, 2026 /PRNewswire/ -- Celltrion, Inc. (068270.KS), a leading global biopharmaceutical company, today announced that Jin-Seok Seo, Chief Executive Officer and Hyuk-Jae Lee, Senior Executive Vice President at Celltrion, will present at the 44th Annual J.P.…
Montana Standard
Astellas to Present at 44th Annual J.P. Morgan Healthcare Conference
TOKYO, Jan. 6, 2026 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced it will present at the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12-15, 2026, in San Francisco, Calif. As…
Coverage Details
Bias Distribution
- 57% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium